Table A4. Government Performance and Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures
| GPRA Goals | Actual Performance | Long-Term Goal | |||||
|---|---|---|---|---|---|---|---|
| 2008 | 2009 | 2010 | 2011 | ||||
| Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15–44-years of age) | 104,000 | 100,000 | 113,000 | 89,000 | |||
| a. Prevalence of chlamydia in women ≤25 years at high-risk* | 12.8% | 11.3% | 11.4% | 11.7% | |||
| b. Incidence of gonorrhea/100,000 population in women 15–44 years of age | 285 | 255 | 259 | 288 | |||
| Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population) | 4.5 | 4.6 | 4.5 | 6.0 | |||
| a. Incidence of P&S syphilis/100,000 population, men | 7.6 | 7.8 | 7.9 | 10.2 | |||
| b. Incidence of P&S syphilis/100,000 population, women | 1.5 | 1.4 | 1.1 | 2.1 | |||
| c. Incidence of congenital syphilis/100,000 live births | 10.1 | 10.0 | 8.7 | 17.7 | |||
| d. Black:white rate ratio of P&S syphilis | 8.1:1 | 9.0:1 | 8.0:1 | 9.5:1 | |||
| GPRA Goals | Data Source |
|---|---|
| 1 | National Disease and Therapeutic Index (IMS Health) |
| 1–a | National Job Training Program |
| 1–b | Regional Infertility Prevention Projects (IPP), STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2 | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–a | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–b | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–c | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–d | STD Surveillance System (STDSS), NCHHSTP, CDC |
* Median state-specific chlamydia prevalence/positivity.
GPRA= Government Performance and Results Act; PID= pelvic inflammatory disease; P&S= primary and secondary.
